Vanguard Group’s Utah Medical Products UTMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$10.1M Buy
177,097
+730
+0.4% +$41.6K ﹤0.01% 2895
2025
Q1
$9.88M Sell
176,367
-801
-0.5% -$44.9K ﹤0.01% 2851
2024
Q4
$10.9M Sell
177,168
-4,001
-2% -$246K ﹤0.01% 2906
2024
Q3
$12.1M Buy
181,169
+2,594
+1% +$174K ﹤0.01% 2860
2024
Q2
$11.9M Sell
178,575
-4,566
-2% -$305K ﹤0.01% 2816
2024
Q1
$13M Buy
183,141
+12,402
+7% +$882K ﹤0.01% 2817
2023
Q4
$14.4M Buy
170,739
+2,581
+2% +$217K ﹤0.01% 2754
2023
Q3
$14.5M Buy
168,158
+610
+0.4% +$52.5K ﹤0.01% 2684
2023
Q2
$15.6M Sell
167,548
-1,387
-0.8% -$129K ﹤0.01% 2698
2023
Q1
$16M Buy
168,935
+1,245
+0.7% +$118K ﹤0.01% 2685
2022
Q4
$16.9M Buy
167,690
+872
+0.5% +$87.7K ﹤0.01% 2710
2022
Q3
$14.2M Sell
166,818
-484
-0.3% -$41.3K ﹤0.01% 2782
2022
Q2
$14.4M Buy
167,302
+1,403
+0.8% +$121K ﹤0.01% 2805
2022
Q1
$14.9M Sell
165,899
-23,674
-12% -$2.13M ﹤0.01% 2935
2021
Q4
$19M Sell
189,573
-26,120
-12% -$2.61M ﹤0.01% 2866
2021
Q3
$20M Buy
215,693
+21,419
+11% +$1.99M ﹤0.01% 2861
2021
Q2
$16.5M Sell
194,274
-1,137
-0.6% -$96.7K ﹤0.01% 2931
2021
Q1
$16.9M Buy
195,411
+6,474
+3% +$561K ﹤0.01% 2867
2020
Q4
$15.9M Buy
188,937
+14,905
+9% +$1.26M ﹤0.01% 2752
2020
Q3
$13.9M Buy
174,032
+523
+0.3% +$41.8K ﹤0.01% 2626
2020
Q2
$15.4M Sell
173,509
-5
-0% -$443 ﹤0.01% 2552
2020
Q1
$16.3M Sell
173,514
-1,119
-0.6% -$105K ﹤0.01% 2381
2019
Q4
$18.8M Sell
174,633
-15,123
-8% -$1.63M ﹤0.01% 2562
2019
Q3
$18.2M Buy
189,756
+2,174
+1% +$208K ﹤0.01% 2533
2019
Q2
$18M Buy
187,582
+806
+0.4% +$77.1K ﹤0.01% 2565
2019
Q1
$16.5M Buy
186,776
+6,331
+4% +$559K ﹤0.01% 2593
2018
Q4
$15M Buy
180,445
+578
+0.3% +$48K ﹤0.01% 2578
2018
Q3
$16.9M Buy
179,867
+27,623
+18% +$2.6M ﹤0.01% 2657
2018
Q2
$16.8M Buy
152,244
+25,045
+20% +$2.76M ﹤0.01% 2644
2018
Q1
$12.6M Sell
127,199
-35,271
-22% -$3.49M ﹤0.01% 2710
2017
Q4
$13.2M Buy
162,470
+10,695
+7% +$871K ﹤0.01% 2695
2017
Q3
$11.2M Buy
151,775
+19,847
+15% +$1.46M ﹤0.01% 2757
2017
Q2
$9.55M Sell
131,928
-411
-0.3% -$29.8K ﹤0.01% 2795
2017
Q1
$8.25M Sell
132,339
-3,037
-2% -$189K ﹤0.01% 2845
2016
Q4
$9.85M Buy
135,376
+1,947
+1% +$142K ﹤0.01% 2753
2016
Q3
$7.98M Sell
133,429
-7,757
-5% -$464K ﹤0.01% 2797
2016
Q2
$8.9M Buy
141,186
+3,275
+2% +$206K ﹤0.01% 2706
2016
Q1
$8.63M Buy
137,911
+41,761
+43% +$2.61M ﹤0.01% 2688
2015
Q4
$5.63M Buy
96,150
+9,899
+11% +$580K ﹤0.01% 2934
2015
Q3
$4.65M Buy
86,251
+5,023
+6% +$271K ﹤0.01% 3001
2015
Q2
$4.84M Buy
81,228
+900
+1% +$53.7K ﹤0.01% 3032
2015
Q1
$4.81M Buy
80,328
+2,667
+3% +$160K ﹤0.01% 3014
2014
Q4
$4.66M Buy
77,661
+244
+0.3% +$14.7K ﹤0.01% 2935
2014
Q3
$3.78M Buy
77,417
+1,800
+2% +$87.8K ﹤0.01% 2984
2014
Q2
$3.89M Sell
75,617
-1,801
-2% -$92.7K ﹤0.01% 2975
2014
Q1
$4.48M Buy
77,418
+1,266
+2% +$73.2K ﹤0.01% 2883
2013
Q4
$4.35M Buy
76,152
+7,825
+11% +$447K ﹤0.01% 2871
2013
Q3
$4.06M Buy
68,327
+3,254
+5% +$193K ﹤0.01% 2845
2013
Q2
$3.53M Buy
+65,073
New +$3.53M ﹤0.01% 2855